TAp63 suppress metastasis via miR-133b in colon cancer cells

British Journal of Cancer

Volumn 110, Issue 9, 2014, Pages 2310-2320

  Lin, C W ^a   Li, X R ^a   Zhang, Y ^a   Hu, G ^a   Guo, Y H ^a   Zhou, J Y ^a   Du, J ^a   Lv, L ^a   Gao, K ^a   Deng, H ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

colon cancer; metastasis; microRNA 133b; RhoA; TAp63

Indexed keywords

MICRORNA; MICRORNA 133B; PROTEIN P53; PROTEIN TAP 63; RHO KINASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL; CELL INVASION; CELL JUNCTION; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; CONSENSUS SEQUENCE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

COLONIC NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; MICRORNAS; NEOPLASM METASTASIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84899954953     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.118     Document Type: Article

References (35)

1. Antonini D, Russo MT, De Rosa L, Gorrese M, Del Vecchio L, Missero C (2010) Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells. J Invest Dermatol 130: 1249-1257.
2. Akcakaya P, Ekelund S, Kolosenko I, Caramuta S, Ozata DM, Xie H, Lindforss U, Olivecrona H, Lui WO (2011) miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol 39: 311-318.
3. Anura A, Das RK, Pal M, Bag S, Conjeti S, Sheet D, Paul RR, Sengupta S, Ray AK, Chakraborty C, Chatterjee J (2013) Pro-emt and neo-angiogenic attributes of oral sub-mucous fibrosis and visualization of stage progression panorama through automated image stitching. J Cell Commun Signal 7(1): 94.
4. Carroll DK, Carroll JS, Leong CO, Cheng F, Brown M, Mills AA, Brugge JS, Ellisen LW (2006) p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol 8: 551-561.
5. Chen Z, Saad R, Jia P, Peng D, Zhu S, Washington MK, Zhao Z, Xu Z, El-Rifai W (2013) Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. Cancer 119: 1985-1993.
6. Cheng IK, Tsang BC, Lai KP, Ching AK, Chan AW, To KF, Lai PB, Wong N (2012) GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling. J Pathol 228(4): 575-585.
7. Choi W, Shah JB, Tran M, Svatek R, Marquis L, Lee IL, Yu D, Adam L, Wen S, Shen Y, Dinney C, McConkey DJ, Siefker-Radtke A (2012) p63 expression defines a lethal subset of muscle-invasive bladder cancers. PLoS One 7(1): e30206.
8. Gallegos JR, Litersky J, Lee H, Sun Y, Nakayama K, Nakayama K, Lu H (2008) SCF TrCP1 activates and ubiquitylates TAp63gamma. J Biol Chem 283: 66-75.
9. Gressner O, Schilling T, Lorenz K, Schulze Schleithoff E, Koch A, Schulze-Bergkamen H, Lena AM, Candi E, Terrinoni A, Catani MV, Oren M, Melino G, Krammer PH, Stremmel W, Müller M (2005) TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J 24: 2458-2471.
10. Gu X, Lundqvist EN, Coates PJ, Thurfjell N, Wettersand E, Nylander K (2006) Dysregulation of TAp63 mRNA and protein levels in psoriasis. J Invest Dermatol 126: 137-141.
11. Gulhati P, Bowen KA, Liu J, Stevens PD, Rychahou PG, Chen M, Lee EY, Weiss HL, O'Connor KL, Gao T, Evers BM (2011) mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res 71: 3246-3256.
12. Hsueh YJ, Kuo PC, Chen JK (2013) Transcriptional regulators of the DNp63: their role in limbal epithelial cell proliferation. J Cell Physiol 228: 536-546.
13. Hu G, Chen D, Li X, Yang K, Wang H, Wu W (2010) miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo. Cancer Biol Ther 10: 190-197.
14. Hutchison N, Hendry BM, Sharpe CC (2009) Rho isoforms have distinct and specific functions in the process of epithelial to mesenchymal transition in renal proximal tubular cells. Cell Signal 21: 1522-1531.
15. Kanlaya R, Sintiprungrat K, Thongboonkerd V (2013) Secreted products of macrophages exposed to calcium oxalate crystals induce epithelial mesenchymal transition of renal tubular cells via RhoA-dependent TGFb1 pathway. Cell Biochem Biophys 67: 1207-1215.
16. Knouf EC, Garg K, Arroyo JD, Correa Y, Sarkar D, Parkin RK, Wurz K, O'Briant KC, Godwin AK, Urban ND, Ruzzo WL, Gentleman R, Drescher CW, Swisher EM, Tewari M (2011) An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription. Nucleic Acids Res 40: 499-510.
17. Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ (2008) MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 28: 6773-6784.
18. Lo Iacono M, Monica V, Saviozzi S, Ceppi P, Bracco E, Papotti M, Scagliotti GV (2011) p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue. J Thorac Oncol 6: 473-481.
19. Loboda A, Nebozhyn MV, Watters JW, Buser CA, Shaw PM, Huang PS, Van't Veer L, Tollenaar RA, Jackson DB, Agrawal D, Dai H, Yeatman TJ (2011) EMT is the dominant program in human colon cancer. BMC Med Genomics 4: 9.
20. Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, Yakhini Z (2009) Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One 4: e8003.
21. Ortt K, Sinha S (2006) Derivation of the consensus DNA-binding sequence for p63reveals unique requirements that are distinct from p53. FEBS Lett 580: 4544-4550.
22. Qin W, Dong P, Ma C, Mitchelson K, Deng T, Zhang L, Sun Y, Feng X, Ding Y, Lu X, He J, Wen H, Cheng J (2011) MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways. Oncogene 31: 4067-4075.
23. Serber Z, Lai HC, Yang A, Ou HD, Sigal MS, Kelly AE, Darimont BD, Duijf PH, Van Bokhoven H, McKeon F, Dötsch V (2002) A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. Mol Cell Biol 22: 8601-8611.
24. Struckhoff AP, Rana MK, Worthylake RA (2011) RhoA can lead the way in tumor cell invasion and metastasis. Front Biosci 16: 1915-1926.
25. Suh EK, Yang A, Kettenbach A, Bamberger C, Michaelis AH, Zhu Z, Elvin JA, Bronson RT, Crum CP, McKeon F (2006) p63 protects the female germ line during meiotic arrest. Nature 444: 624-628.
26. Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin YL, Leung ML, El-Naggar A, Creighton CJ, Suraokar MB, Wistuba I, Flores ER (2010) p63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467: 986-990.
27. Tavares AL, Mercado-Pimentel ME, Runyan RB, Kitten GT (2006) TGF beta-mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heart. Dev Dyn 235: 1589-1598.
28. Tran MN, Choi W, Navai N, Wszolek MF, Lee I-LC, Siefker-Radtke AO, McConkey DJ (2012) P63 inhibits epithelial-mesenchymal transition by promoting the expression of miR205 in human bladder cancer cells. Cancer Res 72(8 Supplement 1): LB-472.
29. Tucci P, Agostini M, Grespi F, Markert EK, Terrinoni A, Vousden KH, Muller PA, Dötsch V, Kehrloesser S, Sayan BS, Giaccone G, Lowe SW, Takahashi N, Vandenabeele P, Knight RA, Levine AJ, Melino G (2012) Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proc Natl Acad Sci USA 109: 15312-15317.
30. Wen D, Li S, Ji F, Cao H, Jiang W, Zhu J, Fang X (2013) miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer. Tumour Biol 34: 793-803.
31. Wu G, Nomoto S, Hoque MO, Dracheva T, Osada M, Lee CC, Dong SM, Guo Z, Benoit N, Cohen Y, Rechthand P, Califano J, Moon CS, Ratovitski E, Jen J, Sidransky D, Trink B (2003) DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res 63: 2351-2357.
32. Wu N, Sulpice E, Obeid P, Benzina S, Kermarrec F, Combe S, Gidrol X (2012) The miR-17 family links p63 protein to MAPK signaling to promote the onset of human keratinocyte differentiation. PLoS One 7: e45761.
33. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, Andrews NC, Caput D, McKeon F (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominantnegative activities. Mol Cell 2: 305-316.
34. Yau WL, Lam CS, Ng L, Chow AK, Chan ST, Chan JY, Wo JY, Ng KT, Man K, Poon RT, Pang RW (2013) Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process. PLoS One 8: e57882.
35. Zhang Y, Yan W, Chen X (2014) P63 regulates tubular formation via epithelial-to-mesenchymal transition. Oncogene 33(12): 1548-1557.